Quantcast

Latest Uroplasty Inc. Stories

2014-10-15 08:29:18

Brings 30 Years of Healthcare Delivery System Leadership Experience to Uroplasty MINNEAPOLIS, Oct. 15, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today that Kenneth H. Paulus has been appointed to the Company's Board of Directors effective October 15, 2014. Mr. Paulus will chair the Board's compensation committee and serve on...

2014-10-09 08:27:12

MINNEAPOLIS, Oct. 9, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the second quarter ended September 30, 2014 after the market close on Thursday, October 23, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, October 23, 2014 at 4:30 p.m. Eastern Time (3:30...

2014-09-10 08:29:51

MINNEAPOLIS, Sept. 10, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 5(th) Annual Craig-Hallum Alpha Select Conference on Thursday, September 18. Brett Reynolds, SVP and CFO, and Darin Hammers, SVP of Global Sales and Marketing, will present at 12:00pm ET and meet with investors one on one at...

2014-08-11 16:28:13

MINNEAPOLIS, Aug. 11, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services (NGS) has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for...

2014-08-06 08:30:46

MINNEAPOLIS, Aug. 6, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13. Rob Kill, President and CEO, will present at 5:00pm ET and meet with investors one on one at the conference at the Intercontinental Hotel Boston....

2014-07-24 16:26:58

~ Urgent PC Sales Up 19% in Fiscal First Quarter MINNEAPOLIS, July 24, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first quarter ended June 30, 2014. Global revenue for the Company's Urgent(®) PC Neuromodulation System grew 19% to $4.1 million, as compared to $3.4 million in the first quarter...

2014-07-10 08:27:22

MINNEAPOLIS, July 10, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the first quarter ended June 30, 2014 after the market close on Thursday, July 24, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, July 24, 2014 at 4:30 p.m. Eastern Time (3:30 p.m. Central...

2014-06-30 08:29:46

MINNEAPOLIS, June 30, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, reported that in the recently updated Overactive Bladder (OAB) treatment guideline from the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Percutaneous Tibial Nerve Stimulation (PTNS) is...

2014-06-16 08:27:52

MINNEAPOLIS, June 16, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24. Rob Kill, President and CEO, will present at 1:00pm ET and meet with investors one on one at the conference at The Westin New York Grand Central. Attendance...

2014-06-02 08:29:20

~Roche Brings Deep Healthcare Industry and Business Strategy Experience MINNEAPOLIS, June 2, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Kevin H. Roche has been appointed to the Company's Board of Directors effective May 29, 2014. Mr. Roche will chair the Nominating Committee and also serve as a member of Uroplasty's...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin